Skip to content
Satori Pharmaceuticals logo — Pioneering advanced therapies for Alzheimer's, Parkinson's,...

Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Founded 2005 Venture round Total: $47.32M Health Care, Pharmaceutical

General Information

Company Name Satori Pharmaceuticals
Founded Year 2005
Industries Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Satori Pharmaceuticals. To contact Satori Pharmaceuticals, visit satoripharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Satori Pharmaceuticals compare?

A PDF of Satori Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Satori Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Satori Pharmaceuticals

Satori Pharmaceuticals, founded in 2005, is a neuroscience company dedicated to pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases. The company's slogan, "Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases," reflects its commitment to developing innovative treatments. Satori Pharmaceuticals focuses on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders, operating within the Health Care and Pharmaceutical industries. The company received a significant $15.00M investment in its Venture Round on 23 February 2012, with participation from prominent investors including New Enterprise Associates, InterWest Partners, and Prospect Venture Partners. This investment underscores the confidence of major players in the venture capital space in Satori Pharmaceuticals' potential for groundbreaking advancements in the treatment of neurodegenerative diseases.

Business keywords: neuroscience, Alzheimer's, Parkinson's, disease-modifying therapies, neurodegenerative diseases, pharmaceuticals, drug discovery, disease research, neurological disorders

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.00M 3
New Enterprise Associates, InterWest Partners +1
23 Feb 2012
Series B $7.00M 4
New Enterprise Associates, InterWest Partners +2
05 Jan 2011
Venture Round $315.00K -
05 Apr 2010
Series A $22.00M 3
New Enterprise Associates, InterWest Partners +1
08 Jan 2009
Venture Round $3.00M -
01 Jan 2005

Satori Pharmaceuticals Alternatives & Competitors

View All Alternatives
Satori Pharmaceuticals vs

Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-relate...

Venture round
11-50 employees
Biotechnology, Health Care
Satori Pharmaceuticals vs
ALSP, Inc.
ALSP, Inc. United States

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative solutions...

Debt Financing
2 employees
Biotechnology, Health Care
Satori Pharmaceuticals vs
Wren Therapeutics
Wren Therapeutics United Kingdom

Stopping the wave of neurodegeneration at its source

Venture round
34 employees
Biopharma, Biotechnology

FAQ About Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.
Satori Pharmaceuticals was founded in 2005.
Satori Pharmaceuticals operates in Health Care and Pharmaceutical. Its work centres on neuroscience, Alzheimer's, Parkinson's and disease-modifying therapies.
Satori Pharmaceuticals has completed 5 funding rounds, raising a total of $47.32M. The latest funding stage is Venture round.
Top alternatives and competitors to Satori Pharmaceuticals include Accera, ALSP, Inc., Wren Therapeutics, Alector, Cognition Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Satori Pharmaceuticals and Accera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Satori Pharmaceuticals, https://bouncewatch.com/company/satori-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout